Complement in neuroprotection and neurodegeneration

被引:54
|
作者
Yanamadala, Vijay [1 ]
Friedlander, Robert M. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Neuroapoptosis Lab,Dept Neurosurg, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
APOPTOTIC CELL-DEATH; ANAPHYLATOXIN C5A; PROTECTS OLIGODENDROCYTES; ALZHEIMERS-DISEASE; EXPRESSION; RECEPTOR; ACTIVATION; SYSTEM; NEURONS; BRAIN;
D O I
10.1016/j.molmed.2009.12.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute neurodegeneration is associated with high morbidity and mortality, and there are few effective treatments. Inflammation is central to the process of neuronal death, yet the roles of the complement cascade in this process have proven to be complex and hard to unravel. The complement cascade is involved in triggering cell death and recruiting cells of the immune system to sites of inflammation, including the brain. However, complement might also have important neuroprotective roles that are only now coming to light. Recent evidence suggests that targeted activation of complement might be a potential approach for treatment of stroke and other acute neurodegenerative diseases. Here, we review these novel neuroprotective roles of the complement cascade, focusing on signaling pathways that might provide new therapeutic targets in acute neuronal injury.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 50 条
  • [41] Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons
    Ullah, Ikram
    Ullah, Najeeb
    Naseer, Muhammad Imran
    Lee, Hae Young
    Kim, Myeong Ok
    BMC NEUROSCIENCE, 2012, 13
  • [42] NMDA preconditioning and neuroprotection in vivo: Delayed onset of kainic acid-induced neurodegeneration and c-Fos attenuation in CA3a neurons
    Mohammadi, Shirin
    Pavlik, Alfred
    Krajci, Dimitrolos
    Al-Sarraf, Hameed
    BRAIN RESEARCH, 2009, 1256 : 162 - 172
  • [43] Intracerebral injections of DNA nanoparticles encoding for a therapeutic gene provide partial neuroprotection in an animal model of neurodegeneration
    Yurek, David
    Hasselrot, Ulla
    Sesenoglu-Laird, Ozge
    Padegimas, Linas
    Cooper, Mark
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (07) : 2209 - 2217
  • [44] Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40)
    Miguel-Hidalgo, JJ
    Alvarez, XA
    Cacabelos, R
    Quack, G
    BRAIN RESEARCH, 2002, 958 (01) : 210 - 221
  • [45] Neurodegeneration by Activation of the Microglial Complement-Phagosome Pathway
    Bodea, Liviu-Gabriel
    Wang, Yiner
    Linnartz-Gerlach, Bettina
    Kopatz, Jens
    Sinkkonen, Lasse
    Musgrove, Ruth
    Kaoma, Tony
    Muller, Arnaud
    Vallar, Laurent
    Di Monte, Donato A.
    Balling, Rudi
    Neumann, Harald
    JOURNAL OF NEUROSCIENCE, 2014, 34 (25) : 8546 - 8556
  • [46] Complement Factor B Inhibition or Deletion Is Not Sufficient to Prevent Neurodegeneration in a Murine Model of Glaucoma
    Dolan, Katie
    Liao, Sha-Mei
    Crowley, Maura
    Xiang, Chuanxi
    Adams, Christopher M.
    Brown, Ann
    Vo, Nhi
    Chen, Amy
    Delgado, Omar
    Buchanan, Natasha
    Guo, Chenying
    Prasanna, Ganesh
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 40 (08) : 524 - 535
  • [47] Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord
    Ohmi, Yuhsuke
    Ohkawa, Yuki
    Tajima, Orie
    Sugiura, Yasuo
    Furukawa, Keiko
    Furukawa, Koichi
    JOURNAL OF NEUROINFLAMMATION, 2014, 11
  • [49] TYPE A MONOAMINE OXIDASE REGULATES LIFE AND DEATH OF NEURONS IN NEURODEGENERATION AND NEUROPROTECTION
    Naoi, Makoto
    Maruyama, Wakako
    Inaba-Hasegawa, Keiko
    Akao, Yukihiro
    MONOAMINE OXIDASES AND THEIR INHIBITORS, 2011, 100 : 85 - 106
  • [50] Complement C3 Inhibition Modulates Neurodegeneration in Chronic Traumatic Brain Injury
    Boulos, Mary Ellene
    Bray, Michael Johnathan Charles
    JOURNAL OF NEUROSCIENCE, 2018, 38 (33) : 7201 - 7203